@article{oai:nagasaki-u.repo.nii.ac.jp:00002514,
 author = {Kosai, Kosuke and Kaku, Norihito and Uno, Naoki and Saijo, Tomomi and Morinaga, Yoshitomo and Imamura, Yoshifumi and Hasegawa, Hiroo and Miyazaki, Taiga and Izumikawa, Koichi and Mukae, Hiroshi and Yanagihara, Katsunori},
 journal = {The Open Microbiology Journal},
 month = {May},
 note = {Background: Carbapenems, fluoroquinolones (FQs), and aminoglycosides (AGs) are key drugs for treating Pseudomonas aeruginosa infections, and accumulation of drug resistances make antibiotic therapy difficult.
Methods: We evaluated 169 patients with imipenem (IPM)-resistant P. aeruginosa and compared patient background and microbiological characteristics between groups with or without FQ resistance. Similar analyses were performed for AG. Results: Of the 169 IPM-resistant strains, 39.1% showed resistance to FQs and 7.1% to AGs. The frequency of exposure to FQs within 90 days previously was higher in the group with FQ resistance (45.5%) than in the group without FQ resistance (13.6%). Similarly, 33.3% of patients in the group with AG resistance had been previously administered AGs, higher than the 7.6% of patients without AG resistance. Frequencies of metallo-β-lactamase (MBL) production were higher in the group with FQ or AG resistance (16.7% or 33.3%) than in the group without FQ or AG resistance (2.9% or 6.4%). Multivariate analyses showed exposures to FQs or AGs were related to the respective resistances. MBL production was a common factor for resistance to FQs or AGs, in addition to IPM-resistant P. aeruginosa. Conclusion: As well as promoting appropriate use of antibiotics, MBL production should be detected as a target of intervention for infection control., The Open Microbiology Journal, 11, pp.92-97; 2017},
 pages = {92--97},
 title = {Risk Factors for Acquisition of Fluoroquinolone or Aminoglycoside Resistance in Addition to Carbapenem Resistance in Pseudomonas aeruginosa},
 volume = {11},
 year = {2017}
}